$FGEN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in FIBROGEN INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in FIBROGEN INC. Get notifications about new insider transactions in FIBROGEN INC for free.
Page: < prev 1 ... 8 9 10 11 12 13 14 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 09 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 4.03 | 14,091 | 56,716 | 239,545 | |
Sep 09 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 18.83 | 18,899 | 355,868 | 3,365,628 | 3.4 M to 3.4 M (-0.56 %) |
Sep 09 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 4.03 | 14,091 | 56,716 | 3,384,527 | 3.4 M to 3.4 M (+0.42 %) |
Sep 09 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 19.14 | 18,899 | 361,727 | 3,370,436 | 3.4 M to 3.4 M (-0.56 %) |
Sep 09 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 4.03 | 14,091 | 56,716 | 3,389,335 | 3.4 M to 3.4 M (+0.42 %) |
Sep 02 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Payment of Exercise | F | 17.33 | 4,688 | 81,243 | 3,375,244 | 3.4 M to 3.4 M (-0.14 %) |
Sep 02 2016 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Payment of Exercise | F | 17.33 | 1,410 | 24,435 | 208,847 | 210.3 K to 208.8 K (-0.67 %) |
Sep 02 2016 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Payment of Exercise | F | 17.33 | 1,410 | 24,435 | 136,704 | 138.1 K to 136.7 K (-1.02 %) |
Aug 29 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 4.03 | 14,091 | 56,716 | 253,636 | |
Aug 29 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 4.03 | 14,091 | 56,716 | 267,727 | |
Aug 29 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 17.81 | 18,899 | 336,591 | 3,379,932 | 3.4 M to 3.4 M (-0.56 %) |
Aug 29 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 4.03 | 14,091 | 56,716 | 3,398,831 | 3.4 M to 3.4 M (+0.42 %) |
Aug 29 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 18.15 | 1,200 | 21,780 | 3,384,740 | 3.4 M to 3.4 M (-0.04 %) |
Aug 29 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 17.76 | 17,699 | 314,334 | 3,385,940 | 3.4 M to 3.4 M (-0.52 %) |
Aug 29 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 4.03 | 14,091 | 56,716 | 3,403,639 | 3.4 M to 3.4 M (+0.42 %) |
Jul 28 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 4.03 | 14,091 | 56,716 | 281,818 | |
Jul 28 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 4.03 | 14,091 | 56,716 | 295,909 | |
Jul 28 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 18.41 | 18,899 | 347,885 | 3,389,548 | 3.4 M to 3.4 M (-0.55 %) |
Jul 28 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 4.03 | 14,091 | 56,716 | 3,408,447 | 3.4 M to 3.4 M (+0.42 %) |
Jul 28 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 18.57 | 4,100 | 76,137 | 3,394,356 | 3.4 M to 3.4 M (-0.12 %) |
Jul 28 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 18.28 | 14,799 | 270,526 | 3,398,456 | 3.4 M to 3.4 M (-0.43 %) |
Jul 28 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 4.03 | 14,091 | 56,716 | 3,413,255 | 3.4 M to 3.4 M (+0.41 %) |
Jul 14 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 17.24 | 10,800 | 186,192 | 3,399,164 | 3.4 M to 3.4 M (-0.32 %) |
Jul 14 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 16.96 | 2,700 | 45,792 | 3,409,964 | 3.4 M to 3.4 M (-0.08 %) |
Jul 14 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 17.81 | 13,500 | 240,435 | 3,412,664 | 3.4 M to 3.4 M (-0.39 %) |
Jun 30 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 16.17 | 13,500 | 218,295 | 3,426,164 | 3.4 M to 3.4 M (-0.39 %) |
Jun 30 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 16.17 | 13,500 | 218,295 | 3,426,164 | 3.4 M to 3.4 M (-0.39 %) |
Jun 30 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 16.21 | 100 | 1,621 | 3,439,664 | 3.4 M to 3.4 M (0.00 %) |
Jun 30 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 16.21 | 100 | 1,621 | 3,439,664 | 3.4 M to 3.4 M (0.00 %) |
Jun 30 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 15.87 | 13,400 | 212,658 | 3,439,764 | 3.5 M to 3.4 M (-0.39 %) |
Jun 30 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 15.87 | 13,400 | 212,658 | 3,439,764 | 3.5 M to 3.4 M (-0.39 %) |
Jun 16 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 16.49 | 13,500 | 222,615 | 3,453,164 | 3.5 M to 3.5 M (-0.39 %) |
Jun 16 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 16.47 | 13,500 | 222,345 | 3,466,664 | 3.5 M to 3.5 M (-0.39 %) |
Jun 16 2016 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Sell | S | 16.49 | 1,796 | 29,616 | 138,114 | 139.9 K to 138.1 K (-1.28 %) |
Jun 14 2016 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Sell | S | 17.96 | 2,344 | 42,098 | 210,257 | 212.6 K to 210.3 K (-1.10 %) |
Jun 10 2016 | FGEN | FIBROGEN INC | EDWARDS JEFFREY L | Director | Option Exercise | A | 19.05 | 12,000 | 228,600 | 12,000 | |
Jun 10 2016 | FGEN | FIBROGEN INC | Henderson Jeffrey William | Director | Option Exercise | A | 19.05 | 12,000 | 228,600 | 12,000 | |
Jun 10 2016 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Option Exercise | A | 19.05 | 12,000 | 228,600 | 12,000 | |
Jun 10 2016 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Option Exercise | A | 19.05 | 12,000 | 228,600 | 12,000 | |
Jun 10 2016 | FGEN | FIBROGEN INC | STERN JULIAN N | Director | Option Exercise | A | 19.05 | 12,000 | 228,600 | 12,000 | |
Jun 10 2016 | FGEN | FIBROGEN INC | Schoeneck James A | Director | Option Exercise | A | 19.05 | 12,000 | 228,600 | 12,000 | |
Jun 10 2016 | FGEN | FIBROGEN INC | Routti Jorma | Director | Option Exercise | A | 19.05 | 12,000 | 228,600 | 12,000 | |
Jun 10 2016 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Option Exercise | A | 19.05 | 12,000 | 228,600 | 12,000 | |
Jun 10 2016 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Option Exercise | A | 19.05 | 12,000 | 228,600 | 12,000 | |
Jun 10 2016 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Option Exercise | A | 19.05 | 12,000 | 228,600 | 12,000 | |
Jun 03 2016 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Payment of Exercise | F | 18.89 | 1,410 | 26,635 | 212,601 | 214 K to 212.6 K (-0.66 %) |
Jun 03 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 18.81 | 13,500 | 253,935 | 3,480,164 | 3.5 M to 3.5 M (-0.39 %) |
Jun 03 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 19.16 | 13,500 | 258,660 | 3,493,664 | 3.5 M to 3.5 M (-0.38 %) |
Jun 03 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Payment of Exercise | F | 18.89 | 4,689 | 88,575 | 3,507,164 | 3.5 M to 3.5 M (-0.13 %) |
Jun 03 2016 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Payment of Exercise | F | 18.89 | 1,958 | 36,987 | 139,910 | 141.9 K to 139.9 K (-1.38 %) |
May 20 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 17.88 | 13,500 | 241,380 | 3,511,853 | 3.5 M to 3.5 M (-0.38 %) |
May 20 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 18.12 | 700 | 12,684 | 3,525,353 | 3.5 M to 3.5 M (-0.02 %) |
May 20 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 17.45 | 12,800 | 223,360 | 3,526,053 | 3.5 M to 3.5 M (-0.36 %) |
May 18 2016 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Sell | S | 17.60 | 6,107 | 107,483 | 214,011 | 220.1 K to 214 K (-2.77 %) |
May 18 2016 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Sell | S | 17.60 | 6,107 | 107,483 | 141,868 | 148 K to 141.9 K (-4.13 %) |
May 03 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 17.61 | 13,500 | 237,735 | 3,538,853 | 3.6 M to 3.5 M (-0.38 %) |
May 03 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 17.95 | 13,500 | 242,325 | 3,552,353 | 3.6 M to 3.6 M (-0.38 %) |
Apr 05 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 21.14 | 3,510 | 74,201 | 3,592,853 | 3.6 M to 3.6 M (-0.10 %) |
Apr 05 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 20.85 | 9,990 | 208,292 | 3,596,363 | 3.6 M to 3.6 M (-0.28 %) |
Apr 05 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 21.30 | 13,500 | 287,550 | 3,606,353 | 3.6 M to 3.6 M (-0.37 %) |
Apr 04 2016 | FGEN | FIBROGEN INC | VALONE FRANK H MD | Chief Medical Offic ... | Option Exercise | M | 3.93 | 10,750 | 42,194 | 2,722 | |
Apr 04 2016 | FGEN | FIBROGEN INC | VALONE FRANK H MD | Chief Medical Offic ... | Sell | S | 21.47 | 200 | 4,294 | 104,684 | 104.9 K to 104.7 K (-0.19 %) |
Apr 04 2016 | FGEN | FIBROGEN INC | VALONE FRANK H MD | Chief Medical Offic ... | Sell | S | 21.10 | 10,550 | 222,647 | 104,884 | 115.4 K to 104.9 K (-9.14 %) |
Apr 04 2016 | FGEN | FIBROGEN INC | VALONE FRANK H MD | Chief Medical Offic ... | Buy | M | 3.93 | 10,750 | 42,194 | 115,434 | 104.7 K to 115.4 K (+10.27 %) |
Mar 22 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 18.87 | 13,500 | 254,745 | 3,619,853 | 3.6 M to 3.6 M (-0.37 %) |
Mar 22 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 18.87 | 100 | 1,887 | 3,633,353 | 3.6 M to 3.6 M (0.00 %) |
Mar 22 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 18.60 | 13,400 | 249,240 | 3,633,453 | 3.6 M to 3.6 M (-0.37 %) |
Mar 17 2016 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Option Exercise | M | 2.90 | 12,000 | 34,800 | 0 | |
Mar 17 2016 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Option Exercise | M | 2.90 | 12,000 | 34,800 | 0 | |
Mar 17 2016 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Option Exercise | M | 2.35 | 24,000 | 56,400 | 0 | |
Mar 17 2016 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Buy | M | 2.90 | 12,000 | 34,800 | 48,000 | 36 K to 48 K (+33.33 %) |
Mar 17 2016 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Buy | M | 2.90 | 12,000 | 34,800 | 36,000 | 24 K to 36 K (+50.00 %) |
Mar 17 2016 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Buy | M | 2.35 | 24,000 | 56,400 | 24,000 | 0 to 24 K |
Mar 08 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 19.85 | 2,200 | 43,670 | 3,646,853 | 3.6 M to 3.6 M (-0.06 %) |
Mar 08 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 18.98 | 11,300 | 214,474 | 3,649,053 | 3.7 M to 3.6 M (-0.31 %) |
Mar 08 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 20.46 | 6,822 | 139,578 | 3,660,353 | 3.7 M to 3.7 M (-0.19 %) |
Mar 08 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 19.75 | 6,678 | 131,891 | 3,667,175 | 3.7 M to 3.7 M (-0.18 %) |
Mar 04 2016 | FGEN | FIBROGEN INC | Yu K Peony | VP, Clinical Develo ... | Payment of Exercise | F | 18.77 | 3,660 | 68,698 | 218,729 | 222.4 K to 218.7 K (-1.65 %) |
Mar 04 2016 | FGEN | FIBROGEN INC | VALONE FRANK H MD | Chief Medical Offic ... | Payment of Exercise | F | 18.77 | 3,921 | 73,597 | 104,684 | 108.6 K to 104.7 K (-3.61 %) |
Mar 04 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Payment of Exercise | F | 18.77 | 8,554 | 160,559 | 3,673,853 | 3.7 M to 3.7 M (-0.23 %) |
Mar 04 2016 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Payment of Exercise | F | 18.77 | 3,660 | 68,698 | 146,586 | 150.2 K to 146.6 K (-2.44 %) |
Mar 03 2016 | FGEN | FIBROGEN INC | VALONE FRANK H MD | Chief Medical Offic ... | Option Exercise | M | 3.50 | 1,714 | 5,999 | 30,028 | |
Mar 03 2016 | FGEN | FIBROGEN INC | VALONE FRANK H MD | Chief Medical Offic ... | Option Exercise | M | 2.90 | 2,508 | 7,273 | 5,000 | |
Mar 03 2016 | FGEN | FIBROGEN INC | VALONE FRANK H MD | Chief Medical Offic ... | Option Exercise | M | 3.93 | 6,528 | 25,622 | 13,472 | |
Mar 03 2016 | FGEN | FIBROGEN INC | VALONE FRANK H MD | Chief Medical Offic ... | Sell | S | 17.61 | 3,490 | 61,461 | 108,605 | 112.1 K to 108.6 K (-3.11 %) |
Mar 03 2016 | FGEN | FIBROGEN INC | VALONE FRANK H MD | Chief Medical Offic ... | Sell | S | 16.47 | 7,260 | 119,579 | 112,095 | 119.4 K to 112.1 K (-6.08 %) |
Mar 03 2016 | FGEN | FIBROGEN INC | VALONE FRANK H MD | Chief Medical Offic ... | Buy | M | 3.50 | 1,714 | 5,999 | 119,355 | 117.6 K to 119.4 K (+1.46 %) |
Mar 03 2016 | FGEN | FIBROGEN INC | VALONE FRANK H MD | Chief Medical Offic ... | Buy | M | 2.90 | 2,508 | 7,273 | 117,641 | 115.1 K to 117.6 K (+2.18 %) |
Mar 03 2016 | FGEN | FIBROGEN INC | VALONE FRANK H MD | Chief Medical Offic ... | Buy | M | 3.93 | 6,528 | 25,622 | 115,133 | 108.6 K to 115.1 K (+6.01 %) |
Feb 24 2016 | FGEN | FIBROGEN INC | Yu K Peony | VP, Clinical Develo ... | Option Exercise | A | 19.39 | 60,000 | 1,163,400 | 60,000 | |
Feb 24 2016 | FGEN | FIBROGEN INC | Yu K Peony | VP, Clinical Develo ... | Grant | A | 0.00 | 35,294 | 0 | 222,389 | 187.1 K to 222.4 K (+18.86 %) |
Feb 24 2016 | FGEN | FIBROGEN INC | VALONE FRANK H MD | Chief Medical Offic ... | Option Exercise | A | 19.39 | 20,000 | 387,800 | 20,000 | |
Feb 24 2016 | FGEN | FIBROGEN INC | VALONE FRANK H MD | Chief Medical Offic ... | Grant | A | 0.00 | 11,765 | 0 | 108,605 | 96.8 K to 108.6 K (+12.15 %) |
Feb 24 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | A | 19.39 | 165,000 | 3,199,350 | 165,000 | |
Feb 24 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 19.16 | 2,700 | 51,732 | 3,682,407 | 3.7 M to 3.7 M (-0.07 %) |
Feb 24 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 18.21 | 10,800 | 196,668 | 3,685,107 | 3.7 M to 3.7 M (-0.29 %) |
Feb 24 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Grant | A | 0.00 | 100,000 | 0 | 3,695,907 | 3.6 M to 3.7 M (+2.78 %) |
Feb 24 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 20.30 | 300 | 6,090 | 3,595,907 | 3.6 M to 3.6 M (-0.01 %) |
Feb 24 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 19.80 | 13,200 | 261,360 | 3,596,207 | 3.6 M to 3.6 M (-0.37 %) |
Feb 24 2016 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Option Exercise | A | 19.39 | 60,000 | 1,163,400 | 60,000 | |
Feb 24 2016 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Grant | A | 0.00 | 35,294 | 0 | 150,246 | 115 K to 150.2 K (+30.70 %) |
Feb 18 2016 | FGEN | FIBROGEN INC | VALONE FRANK H MD | Chief Medical Offic ... | Option Exercise | M | 3.50 | 8,258 | 28,903 | 31,742 | |
Feb 18 2016 | FGEN | FIBROGEN INC | VALONE FRANK H MD | Chief Medical Offic ... | Option Exercise | M | 2.90 | 2,492 | 7,227 | 7,508 | |
Feb 18 2016 | FGEN | FIBROGEN INC | VALONE FRANK H MD | Chief Medical Offic ... | Sell | S | 18.41 | 10,750 | 197,943 | 96,840 | 107.6 K to 96.8 K (-9.99 %) |
Feb 18 2016 | FGEN | FIBROGEN INC | VALONE FRANK H MD | Chief Medical Offic ... | Buy | M | 3.50 | 8,258 | 28,903 | 107,590 | 99.3 K to 107.6 K (+8.31 %) |
Feb 18 2016 | FGEN | FIBROGEN INC | VALONE FRANK H MD | Chief Medical Offic ... | Buy | M | 2.90 | 2,492 | 7,227 | 99,332 | 96.8 K to 99.3 K (+2.57 %) |
Feb 11 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 15.48 | 13,500 | 208,980 | 3,609,407 | 3.6 M to 3.6 M (-0.37 %) |
Feb 11 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 15.58 | 1,600 | 24,928 | 3,622,907 | 3.6 M to 3.6 M (-0.04 %) |
Feb 11 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 15.08 | 11,900 | 179,452 | 3,624,507 | 3.6 M to 3.6 M (-0.33 %) |
Feb 09 2016 | FGEN | FIBROGEN INC | Yu K Peony | VP, Clinical Develo ... | Option Exercise | M | 5.95 | 4,500 | 26,775 | 4,500 | |
Feb 09 2016 | FGEN | FIBROGEN INC | Yu K Peony | VP, Clinical Develo ... | Option Exercise | M | 3.50 | 6,000 | 21,000 | 2,000 | |
Feb 09 2016 | FGEN | FIBROGEN INC | Yu K Peony | VP, Clinical Develo ... | Buy | M | 5.95 | 4,500 | 26,775 | 187,095 | 182.6 K to 187.1 K (+2.46 %) |
Feb 09 2016 | FGEN | FIBROGEN INC | Yu K Peony | VP, Clinical Develo ... | Buy | M | 3.50 | 6,000 | 21,000 | 182,595 | 176.6 K to 182.6 K (+3.40 %) |
Feb 09 2016 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Option Exercise | M | 2.90 | 527 | 1,528 | 0 | |
Feb 09 2016 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Option Exercise | M | 2.90 | 3,100 | 8,990 | 0 | |
Feb 09 2016 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Buy | M | 2.90 | 3,627 | 10,518 | 114,952 | 111.3 K to 115 K (+3.26 %) |
Apr 20 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 19.75 | 13,500 | 266,625 | 3,565,853 | 3.6 M to 3.6 M (-0.38 %) |
Apr 20 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 20.21 | 13,500 | 272,835 | 3,579,353 | 3.6 M to 3.6 M (-0.38 %) |
Jan 29 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 20.17 | 700 | 14,119 | 3,636,407 | 3.6 M to 3.6 M (-0.02 %) |
Jan 29 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 19.58 | 12,800 | 250,624 | 3,637,107 | 3.6 M to 3.6 M (-0.35 %) |
Jan 29 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 19.70 | 900 | 17,730 | 3,649,907 | 3.7 M to 3.6 M (-0.02 %) |
Jan 29 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 19.17 | 12,600 | 241,542 | 3,650,807 | 3.7 M to 3.7 M (-0.34 %) |
Jan 22 2016 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Option Exercise | M | 2.90 | 2,900 | 8,410 | 3,100 | |
Jan 22 2016 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Option Exercise | M | 2.90 | 1,100 | 3,190 | 0 | |
Jan 22 2016 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Buy | M | 2.90 | 4,000 | 11,600 | 111,325 | 107.3 K to 111.3 K (+3.73 %) |
Jan 22 2016 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Sell | S | 22.08 | 1,572 | 34,710 | 160,564 | 162.1 K to 160.6 K (-0.97 %) |
Jan 22 2016 | FGEN | FIBROGEN INC | VALONE FRANK H MD | Chief Medical Offic ... | Option Exercise | M | 2.90 | 10,000 | 29,000 | 10,000 | |
Jan 22 2016 | FGEN | FIBROGEN INC | VALONE FRANK H MD | Chief Medical Offic ... | Buy | M | 2.90 | 10,000 | 29,000 | 96,840 | 86.8 K to 96.8 K (+11.52 %) |
Jan 15 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 23.79 | 7,700 | 183,183 | 3,663,407 | 3.7 M to 3.7 M (-0.21 %) |
Jan 15 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 22.91 | 5,800 | 132,878 | 3,671,107 | 3.7 M to 3.7 M (-0.16 %) |
Jan 15 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 24.42 | 3,900 | 95,238 | 3,676,907 | 3.7 M to 3.7 M (-0.11 %) |
Jan 15 2016 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 23.79 | 9,600 | 228,384 | 3,680,807 | 3.7 M to 3.7 M (-0.26 %) |
Dec 30 2015 | FGEN | FIBROGEN INC | Routti Jorma | Director | Option Exercise | M | 4.03 | 12,000 | 48,300 | 0 | |
Dec 30 2015 | FGEN | FIBROGEN INC | Routti Jorma | Director | Option Exercise | M | 2.00 | 8,000 | 16,000 | 0 | |
Dec 30 2015 | FGEN | FIBROGEN INC | Routti Jorma | Director | Buy | M | 4.03 | 12,000 | 48,300 | 127,840 | 115.8 K to 127.8 K (+10.36 %) |
Dec 30 2015 | FGEN | FIBROGEN INC | Routti Jorma | Director | Buy | M | 2.00 | 8,000 | 16,000 | 115,840 | 107.8 K to 115.8 K (+7.42 %) |
Dec 28 2015 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Sell | S | 30.81 | 3,900 | 120,159 | 162,136 | 166 K to 162.1 K (-2.35 %) |
Dec 28 2015 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Sell | S | 30.94 | 3,900 | 120,666 | 166,036 | 169.9 K to 166 K (-2.29 %) |
Dec 23 2015 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 30.93 | 13,500 | 417,555 | 3,690,407 | 3.7 M to 3.7 M (-0.36 %) |
Dec 23 2015 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 29.95 | 200 | 5,990 | 3,703,907 | 3.7 M to 3.7 M (-0.01 %) |
Dec 23 2015 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 29.26 | 13,300 | 389,158 | 3,704,107 | 3.7 M to 3.7 M (-0.36 %) |
Dec 18 2015 | FGEN | FIBROGEN INC | VALONE FRANK H MD | Chief Medical Offic ... | Gift | G | 0.00 | 2,500 | 0 | 86,840 | 89.3 K to 86.8 K (-2.80 %) |
Dec 17 2015 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Sell | S | 28.95 | 837 | 24,231 | 107,325 | 108.2 K to 107.3 K (-0.77 %) |
Dec 11 2015 | FGEN | FIBROGEN INC | Yu K Peony | VP, Clinical Develo ... | Sell | S | 28.96 | 1,093 | 31,653 | 176,595 | 177.7 K to 176.6 K (-0.62 %) |
Dec 11 2015 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 29.69 | 2,800 | 83,132 | 3,717,407 | 3.7 M to 3.7 M (-0.08 %) |
Dec 11 2015 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 29.10 | 10,700 | 311,370 | 3,720,207 | 3.7 M to 3.7 M (-0.29 %) |
Dec 11 2015 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 30.35 | 6,900 | 209,415 | 3,730,907 | 3.7 M to 3.7 M (-0.18 %) |
Dec 11 2015 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 29.53 | 6,600 | 194,898 | 3,737,807 | 3.7 M to 3.7 M (-0.18 %) |
Dec 10 2015 | FGEN | FIBROGEN INC | MADERO MIGUEL | Director | Option Exercise | M | 2.90 | 12,000 | 34,800 | 0 | |
Dec 10 2015 | FGEN | FIBROGEN INC | MADERO MIGUEL | Director | Option Exercise | M | 18.34 | 6,000 | 110,040 | 6,000 |